After a long wait, the U.S. Supreme Court issued its opinion in Mayo v. Prometheus, an important intellectual property case for the biotechnology industry
Company acquires hematology-
focused FerroKin BioScience in deal worth as much as $325 million; also licenses CNS program from Heptares in potential $190 million agreement
Sigma-Aldrich Corp. announced in April that it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics
Inc., to expand the company’s buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic
markets
Transparent Inc. and Molecular Response Laboratories (MRL) announced in late March that they launch Cell-able
Oncology, a novel 3D cell culture system for pharmaceutical researchers and medical professionals.
In March, Michigan’s House Appropriations Subcommittee on Higher Education said it may withhold $7 million of performance funding from the 2012/2013 state budget for the University of Michigan (U-M) and Michigan State University if U-M does not disclose the number of hESCs the school is using in its research.
Patents do not stifle innovation any more than copyright laws stifle creativity. In a similar vein, homeownership does not stifle
homelessness, and marriage does not necessarily stifle infidelity.
The
only way we will see true, long-term success in treating diabetes is by fundamentally rethinking this disease and shifting our focus to pursue a targeted,
personalized approach to prevention, diagnosis and treatment.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.